A business in context

CPMV research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001683168-26-006426

  2. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001683168-26-004152

  3. 10-K · Annual report

    Report date 2025-12-31 · 0001683168-26-002977

  4. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001683168-25-008543

  5. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001683168-25-006318

  6. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001683168-25-003880

  7. 10-K · Annual report

    Report date 2024-12-31 · 0001683168-25-002584

  8. 8-K · Current report

    Report date 2024-12-31 · 0001683168-25-000009 · Items 8.01,9.01

  9. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001683168-24-008258

  10. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001683168-24-005676

  11. 8-K · Current report

    Report date 2024-07-23 · 0001683168-24-005057 · Items 5.02

  12. 8-K · Current report

    Report date 2024-05-31 · 0001683168-24-003923 · Items 5.02,9.01

  13. 8-K · Current report

    Report date 2024-05-21 · 0001683168-24-003732 · Items 4.01,9.01

  14. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001683168-24-003375

  15. 8-K · Current report

    Report date 2024-04-26 · 0001683168-24-002761 · Items 7.01,8.01,9.01

  16. 8-K · Current report

    Report date 2024-04-17 · 0001683168-24-002534 · Items 5.02

  17. 10-K · Annual report

    Report date 2023-12-31 · 0001683168-24-002402

  18. 8-K · Current report

    Report date 2024-03-22 · 0001683168-24-001813 · Items 1.01,1.02

  19. 10-Q · Quarterly report

    Report date 2023-09-30 · 0001683168-23-007588

  20. 10-Q · Quarterly report

    Report date 2023-06-30 · 0001683168-23-005245

  21. 8-K · Current report

    Report date 2023-06-21 · 0001683168-23-004424 · Items 1.01,8.01,9.01

  22. 10-Q · Quarterly report

    Report date 2023-03-31 · 0001683168-23-003253

  23. 8-K · Current report

    Report date 2023-05-02 · 0001683168-23-002890 · Items 5.02

  24. 10-K · Annual report

    Report date 2022-12-31 · 0001683168-23-001237

  25. 10-Q · Quarterly report

    Report date 2022-09-30 · 0001683168-22-007181

  26. 10-Q · Quarterly report

    Report date 2022-06-30 · 0001683168-22-005321

  27. 8-K · Current report

    Report date 2022-07-06 · 0001683168-22-004893 · Items 1.01,9.01

  28. 10-Q · Quarterly report

    Report date 2022-03-31 · 0001683168-22-003373

  29. 8-K · Current report

    Report date 2022-05-04 · 0001683168-22-003217 · Items 1.01,7.01,9.01

  30. 4 · Ownership change

    Report date 2022-02-18 · 0001683168-22-001214

  31. 4 · Ownership change

    Report date 2022-02-18 · 0001683168-22-001213

  32. 4 · Ownership change

    Report date 2022-02-18 · 0001683168-22-001212

  33. 4 · Ownership change

    Report date 2022-02-18 · 0001683168-22-001211

  34. 4 · Ownership change

    Report date 2022-02-18 · 0001683168-22-001210

  35. 8-K · Current report

    Report date 2022-02-18 · 0001683168-22-001209 · Items 1.01,2.03,3.02,3.03,9.01

  36. 10-K · Annual report

    Report date 2021-12-31 · 0001683168-22-000466

  37. 10-Q · Quarterly report

    Report date 2021-09-30 · 0001683168-21-005191

  38. 4 · Ownership change

    Report date 2021-05-07 · 0001683168-21-001855

  39. 4 · Ownership change

    Report date 2021-05-07 · 0001683168-21-001854

  40. 4 · Ownership change

    Report date 2021-04-29 · 0001683168-21-001650

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000836564Mosaic ImmunoEngineering Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • PATRIOT SCIENTIFIC CORP · former SEC name · 1995-12-11 to 2020-11-19

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗